Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage.

Authors:
Du N; Zhang B; Zhang Y.

Journal:
Can Respir J

Publication Year: 2023

DOI:
10.1155/2023/4533504

PMCID:
PMC10403328

PMID:
37547297

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Exp…
Wang L; Xu L; Han S and 1 more (2024) - Transparency Score: 2/6
Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibro…
Akira M; Suganuma N. (2024) - Transparency Score: 2/6
Hypersensitivity Pneumonitis: Challenges of a Complex Disease.
Calaras D; David A; Vasarmidi E and 2 more (2024) - Transparency Score: 2/6
A Novel Scale to Assess Humidification during Noninvasive Ventilation: A Prospective Observational …
Pan L; Hong Y; Zhong X and 6 more (2023) - Transparency Score: 2/6
Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbat…
Komura M; Sato T; Suzuki Y and 10 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"This work was supported by the Key Research and Development Program of Shaanxi (no. 2019SF-044)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025